Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R9KG
|
||||
Former ID |
DIB015327
|
||||
Drug Name |
Temanogrel
|
||||
Synonyms |
Temanogrel hydrochloride; APD-791; 5-HT 2a inverse agonist (arterial thrombosis), Arena Pharmaceutical
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cardiovascular disorder [ICD10:I00-I99] | Phase 1 | [524599] | ||
Company |
Arena Pharmaceuticals; Arena Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H28N4O4
|
||||
Canonical SMILES |
C(=O)(c1cc(ccc1)OC)Nc1cc(c(cc1)OCCN1CCOCC1)c1n(ncc1)C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Agonist | [526792], [550267] | |
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.